Comparison
Omega-3 (DHA/EPA) vs Magnesium Glycinate
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Magnesium Glycinate
Chelated magnesium with high bioavailability and minimal laxative effect. The de facto sleep magnesium.
| Field | Omega-3 (DHA/EPA) | Magnesium Glycinate |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 200–400mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 1200 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Magnesium Glycinate are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Magnesium Glycinate Chelated magnesium with high bioavailability and minimal laxative effect.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Magnesium Glycinate (evidence B, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Magnesium Glycinate if
Magnesium Glycinate is the better fit when your goal aligns with its mechanism (Magnesium chelated with glycine for high bioavailability and minimal laxative effect) and the dose range (200–400mg) suits your protocol. Half-life is —h.